|
Petmed Express, Inc. - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Petmed Express, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Petmed Express, Inc.. The Group's principal activity is to markets prescription and non-prescription pet medications, and other health products for dogs, cats and horses direct to the consumer. It offers an attractive alternative for obtaining pet medications in terms of convenience, price and speed of delivery. The Group's current product line contains approximately 750 skus. These products include a majority of the well-known brands of medication, such as Frontline Plus(R), K9 Advantix(R), Advantage(R), Heartgard Plus(R), Sentinel(R), Interceptor(R), Program(R), Revolution(R), Deramaxx(R) and Rimadyl(R).It markets products through national television, online and direct mail/print advertising campaigns, which aim to increase the recognition of the 1-800-PetMeds brand name, and PetMeds family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers and maximize repeat purchases.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
